Jun 14, 2020
Sobi and Sanofi Donate up to 500 Million Additional IUs of Clotting Factor to WFH Humanitarian Aid Program
May 13, 2020
Artax Biopharma Appoints Joseph Lobacki as Chief Executive Officer, Announces Expanded Management Team
Apr 28, 2020
CANbridge Pharmaceuticals Appoints Acting Chief Scientific Officer
Jan 10, 2020
Candel Therapeutics Appoints Sandra E. Poole as Chief Operating Officer
Dec 06, 2019
CStone appoints seasoned pharmaceutical executive Shirley Zhao as the General Manager for Greater China and Head of Commercial
Aug 15, 2019
Medical Science Liaison Society Announces Finalists for the 2019 MSL of the Year Awards
Jul 30, 2019
CANbridge Pharmaceuticals Appoints Senior Vice President, Rare Disease Commercial Operations
Jul 29, 2019
Sanofi delivered solid growth in Q2 2019
Apr 26, 2019
Sanofi delivers strong Q1 2019 business EPS growth of 9.4% at CER
Apr 25, 2019
Gaucher Disease Drugs Market Size Worth $1.71 Billion by 2025: Grand View Research, Inc.
Apr 25, 2019
CANbridge Pharmaceuticals Appoints Chief Financial Officer and Interim Chief Medical Officer
Apr 16, 2019
CANbridge Pharmaceuticals Appoints Chief Financial Officer and Interim Chief Medical Officer
Feb 21, 2019
ProMIS Neurosciences Adds Pharmaceutical Leader Timothy Rothwell to Board of Advisors
Feb 14, 2019
Global Fabry Disease Market Insights, Epidemiology and Market Report 2019
Dec 18, 2018
PTC Therapeutics Deepens Financial and Commercial Expertise of Board with Two New Appointments
Dec 11, 2018
Spherix Global Insights' Quarterly Update on the Multiple Sclerosis Market Reveals a Unique Role for Genzyme's Aubagio As the Only Oral Standard-Efficacy Therapy for First-Line Treatment of Relapsing-Remitting Multiple Sclerosis
Oct 15, 2018
Shining a Light on Diagnosis for Rare Genetic Disease Patients
Sep 03, 2018
Cablivi(TM) (caplacizumab) approved in Europe for adults with acquired thrombotic thrombocytopenic purpura (aTTP)
Aug 29, 2018
2018 NORD Rare Summit to Feature Distinguished Speakers Discussing 'A New Era of Patient-Focused Innovation'
Aug 14, 2018
Sigilon Therapeutics Announces Leadership Transition and Appoints Rare Disease Pioneer Rogerio Vivaldi, M.D., as Chief Executive Officer